5-hydroxymethylcytosine has been researched along with Acute Lymphoid Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, JH; Lodh, A; Poole, CJ; van Riggelen, J | 1 |
| Cao, LL; Jia, M; Liu, H; Pei, L; Wang, H; Yue, Z | 1 |
2 other study(ies) available for 5-hydroxymethylcytosine and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
Topics: 5-Methylcytosine; Animals; Cell Line, Tumor; Cytosine; Dioxygenases; DNA; DNA Methylation; DNA-Binding Proteins; Gene Expression Regulation, Leukemic; Humans; Mice; Mice, Transgenic; Mixed Function Oxygenases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Promoter Regions, Genetic; Protein Processing, Post-Translational; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-myc | 2019 |
The clinical values of dysregulated DNA methylation and demethylation intermediates in acute lymphoblastic leukemia.
Topics: 5-Methylcytosine; Adolescent; Adult; Aged; Area Under Curve; Biomarkers, Tumor; Cell Lineage; Child; Cytosine; Demethylation; DNA Methylation; DNA, Neoplasm; Female; Humans; Male; Middle Aged; Oxidation-Reduction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; ROC Curve; Young Adult | 2019 |